SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 2146343

Cover Image

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 2146343

Enzyme Engineering Market Outlook, Growth Drivers and Opportunities, 2026-2033

PUBLISHED:
PAGES: 195 Pages
DELIVERY TIME: 2-5 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4995
Unprintable PDF & Excel (Multi User License upto 5 users)
USD 8495
Printable PDF & Excel (Enterprise License above 5 users)
USD 10600

Add to Cart

Enzyme Engineering Market Projected to Reach US$5.7 Bn by 2033

Introduction

The global enzyme engineering market is valued at US$3.2 Bn in 2026 and projected to reach US$5.7 Bn by 2033, at a CAGR of 8.6% during 2026-2033. Fairfield Market Research assesses the market through its published product, customer and geographical classifications. The forecast provides a common basis for evaluating commercial priorities across the study period.

Market Insights

The enzyme type breakdown covers Hydrolases, Oxidoreductases, Transferases, Lyases, Isomerases and Ligases. The technology breakdown covers Directed Evolution, Rational Protein Design, Computational and Machine Learning Guided Design and De Novo Enzyme Synthesis. The application breakdown covers Industrial Biocatalysis, Pharmaceutical and Therapeutic, Food and Beverage Processing, Biofuels and Bioenergy and Diagnostics and Biosensors. These distinctions help businesses assess which offerings and customer requirements fall within the market's scope. The global forecast should be read alongside these segment definitions rather than applied uniformly to every individual category.

Within the enzyme type classification, Hydrolases and Oxidoreductases represent separate categories in the report. Keeping these categories distinct helps readers evaluate the fit of an offering before applying the overall market forecast to a specific commercial plan.

Within the technology classification, Directed Evolution and Rational Protein Design represent separate categories in the report. Keeping these categories distinct helps readers evaluate the fit of an offering before applying the overall market forecast to a specific commercial plan.

Drivers

Fairfield's growth discussion addresses manufacturing and performance. These themes provide a starting point for assessing demand conditions and the requirements facing suppliers. Their commercial importance depends on the segment, customer and region concerned. Businesses can use the report's detailed discussion to connect these demand factors with their own portfolios and sales priorities.

Business Opportunity

The opportunity discussion highlights recycling, cloud computing, protein and packaging. Companies evaluating expansion can compare these areas with their existing capabilities, route to market and customer needs. Segment selection and regional positioning remain central to assessing the relevance of the published forecast to an individual business.

Businesses considering Hydrolases can compare its customer requirements with those associated with Oxidoreductases. This comparison can help define a more focused portfolio, identify the appropriate sales audience and establish which questions require additional segment evidence before resources are committed.

Businesses considering Directed Evolution can compare its customer requirements with those associated with Rational Protein Design. This comparison can help define a more focused portfolio, identify the appropriate sales audience and establish which questions require additional segment evidence before resources are committed.

Region Analysis

The geographical scope covers North America, Europe, Asia Pacific, Latin America and Middle East & Africa. Regional comparisons should use the report's own market definitions and forecast period.

Key Players

  • Novonesis
  • BASF SE
  • International Flavors & Fragrances Inc.
  • dsm-firmenich AG
  • Codexis, Inc.
  • Amano Enzyme Inc.
  • AB Enzymes GmbH
  • Dyadic International, Inc.
  • Advanced Enzyme Technologies Limited
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • F. Hoffmann-La Roche Ltd
  • Kerry Group plc
  • Ginkgo Bioworks Holdings, Inc.
  • Arzeda Corp.
  • Creative Enzymes

Segmentation

By Enzyme Type

  • Hydrolases
  • Oxidoreductases
  • Transferases
  • Lyases
  • Isomerases
  • Ligases

By Technology

  • Directed Evolution
  • Rational Protein Design
  • Computational and Machine Learning Guided Design
  • De Novo Enzyme Synthesis

By Application

  • Industrial Biocatalysis
  • Pharmaceutical and Therapeutic
  • Food and Beverage Processing
  • Biofuels and Bioenergy
  • Diagnostics and Biosensors

By End User

  • Pharmaceutical and Biotechnology Companies
  • Contract Research and Development Organisations
  • Food and Beverage Manufacturers
  • Chemical and Industrial Manufacturers
  • Academic and Research Institutes

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Snapshot
  • 1.2. Market Size and Trend Analysis 2026-2033
  • 1.3. Historical Growth 2020-2025
  • 1.4. Key Industry Highlights

2. Market Overview

  • 2.1. Market Definition and Segmentation
  • 2.2. Market Dynamics
    • 2.2.1. Market Growth Drivers
      • 2.2.1.1. Pharmaceutical Makers Shift Synthesis Routes to Engineered Biocatalysts
      • 2.2.1.2. Industrial Decarbonisation Raises Demand for Engineered Industrial Enzymes
    • 2.2.2. Restraints Impact Analysis of Market
      • 2.2.2.1. High Development Costs and Long Enzyme Optimisation Cycles
      • 2.2.2.2. Enzyme Stability Limits Under Harsh Industrial Operating Conditions
    • 2.2.3. Market Opportunities
      • 2.2.3.1. Machine Learning Guided Protein Design Opens New Commercial Space
      • 2.2.3.2. Enzymatic Plastic Recycling Creates a New Revenue Pool
  • 2.3. Category-wise Insights
    • 2.3.1. Why Do Hydrolases Hold the Largest Enzyme Engineering Share?
    • 2.3.2. Directed Evolution Leads While Computational Design Scales Fastest
    • 2.3.3. Industrial Biocatalysis Anchors Demand as Therapeutic Use Accelerates
    • 2.3.4. Pharmaceutical Firms Dominate Spending While Service Providers Expand Quickest

3. Global Enzyme Engineering Market Outlook 2026-2033

  • 3.1. Global Enzyme Engineering Market Outlook, by Enzyme Type, Value (US$ Billion), 2026-2033
    • 3.1.1. Hydrolases
    • 3.1.2. Oxidoreductases
    • 3.1.3. Transferases
    • 3.1.4. Lyases
    • 3.1.5. Isomerases
    • 3.1.6. Ligases
  • 3.2. Global Enzyme Engineering Market Outlook, by Technology, Value (US$ Billion), 2026-2033
    • 3.2.1. Directed Evolution
    • 3.2.2. Rational Protein Design
    • 3.2.3. Computational and Machine Learning Guided Design
    • 3.2.4. De Novo Enzyme Synthesis
  • 3.3. Global Enzyme Engineering Market Outlook, by Application, Value (US$ Billion), 2026-2033
    • 3.3.1. Industrial Biocatalysis
    • 3.3.2. Pharmaceutical and Therapeutic
    • 3.3.3. Food and Beverage Processing
    • 3.3.4. Biofuels and Bioenergy
    • 3.3.5. Diagnostics and Biosensors
  • 3.4. Global Enzyme Engineering Market Outlook, by End User, Value (US$ Billion), 2026-2033
    • 3.4.1. Pharmaceutical and Biotechnology Companies
    • 3.4.2. Contract Research and Development Organisations
    • 3.4.3. Food and Beverage Manufacturers
    • 3.4.4. Chemical and Industrial Manufacturers
    • 3.4.5. Academic and Research Institutes
  • 3.5. Global Enzyme Engineering Market Outlook, by Region, Value (US$ Billion), 2026-2033
    • 3.5.1. North America
    • 3.5.2. Europe
    • 3.5.3. Asia Pacific
    • 3.5.4. Latin America
    • 3.5.5. Middle East & Africa

4. North America Enzyme Engineering Market Outlook 2026-2033

  • 4.1. North America Enzyme Engineering Market Outlook, by Enzyme Type, Value (US$ Billion), 2026-2033
    • 4.1.1. Hydrolases
    • 4.1.2. Oxidoreductases
    • 4.1.3. Transferases
    • 4.1.4. Lyases
    • 4.1.5. Isomerases
    • 4.1.6. Ligases
  • 4.2. North America Enzyme Engineering Market Outlook, by Technology, Value (US$ Billion), 2026-2033
    • 4.2.1. Directed Evolution
    • 4.2.2. Rational Protein Design
    • 4.2.3. Computational and Machine Learning Guided Design
    • 4.2.4. De Novo Enzyme Synthesis
  • 4.3. North America Enzyme Engineering Market Outlook, by Application, Value (US$ Billion), 2026-2033
    • 4.3.1. Industrial Biocatalysis
    • 4.3.2. Pharmaceutical and Therapeutic
    • 4.3.3. Food and Beverage Processing
    • 4.3.4. Biofuels and Bioenergy
    • 4.3.5. Diagnostics and Biosensors
  • 4.4. North America Enzyme Engineering Market Outlook, by End User, Value (US$ Billion), 2026-2033
    • 4.4.1. Pharmaceutical and Biotechnology Companies
    • 4.4.2. Contract Research and Development Organisations
    • 4.4.3. Food and Beverage Manufacturers
    • 4.4.4. Chemical and Industrial Manufacturers
    • 4.4.5. Academic and Research Institutes
  • 4.5. North America Enzyme Engineering Market Outlook, by Country and Subregion, 2026-2033
    • 4.5.1. United States Enzyme Engineering Market Outlook, by Enzyme Type, 2026-2033
    • 4.5.2. United States Enzyme Engineering Market Outlook, by Technology, 2026-2033
    • 4.5.3. United States Enzyme Engineering Market Outlook, by Application, 2026-2033
    • 4.5.4. United States Enzyme Engineering Market Outlook, by End User, 2026-2033
    • 4.5.5. Canada Enzyme Engineering Market Outlook, by Enzyme Type, 2026-2033
    • 4.5.6. Canada Enzyme Engineering Market Outlook, by Technology, 2026-2033
    • 4.5.7. Canada Enzyme Engineering Market Outlook, by Application, 2026-2033
    • 4.5.8. Canada Enzyme Engineering Market Outlook, by End User, 2026-2033

5. Europe Enzyme Engineering Market Outlook 2026-2033

  • 5.1. Europe Enzyme Engineering Market Outlook, by Enzyme Type, Value (US$ Billion), 2026-2033
    • 5.1.1. Hydrolases
    • 5.1.2. Oxidoreductases
    • 5.1.3. Transferases
    • 5.1.4. Lyases
    • 5.1.5. Isomerases
    • 5.1.6. Ligases
  • 5.2. Europe Enzyme Engineering Market Outlook, by Technology, Value (US$ Billion), 2026-2033
    • 5.2.1. Directed Evolution
    • 5.2.2. Rational Protein Design
    • 5.2.3. Computational and Machine Learning Guided Design
    • 5.2.4. De Novo Enzyme Synthesis
  • 5.3. Europe Enzyme Engineering Market Outlook, by Application, Value (US$ Billion), 2026-2033
    • 5.3.1. Industrial Biocatalysis
    • 5.3.2. Pharmaceutical and Therapeutic
    • 5.3.3. Food and Beverage Processing
    • 5.3.4. Biofuels and Bioenergy
    • 5.3.5. Diagnostics and Biosensors
  • 5.4. Europe Enzyme Engineering Market Outlook, by End User, Value (US$ Billion), 2026-2033
    • 5.4.1. Pharmaceutical and Biotechnology Companies
    • 5.4.2. Contract Research and Development Organisations
    • 5.4.3. Food and Beverage Manufacturers
    • 5.4.4. Chemical and Industrial Manufacturers
    • 5.4.5. Academic and Research Institutes
  • 5.5. Europe Enzyme Engineering Market Outlook, by Country and Subregion, 2026-2033
    • 5.5.1. Germany Enzyme Engineering Market Outlook, by Enzyme Type, 2026-2033
    • 5.5.2. Germany Enzyme Engineering Market Outlook, by Technology, 2026-2033
    • 5.5.3. Germany Enzyme Engineering Market Outlook, by Application, 2026-2033
    • 5.5.4. Germany Enzyme Engineering Market Outlook, by End User, 2026-2033
    • 5.5.5. Denmark Enzyme Engineering Market Outlook, by Enzyme Type, 2026-2033
    • 5.5.6. Denmark Enzyme Engineering Market Outlook, by Technology, 2026-2033
    • 5.5.7. Denmark Enzyme Engineering Market Outlook, by Application, 2026-2033
    • 5.5.8. Denmark Enzyme Engineering Market Outlook, by End User, 2026-2033
    • 5.5.9. Netherlands Enzyme Engineering Market Outlook, by Enzyme Type, 2026-2033
    • 5.5.10. Netherlands Enzyme Engineering Market Outlook, by Technology, 2026-2033
    • 5.5.11. Netherlands Enzyme Engineering Market Outlook, by Application, 2026-2033
    • 5.5.12. Netherlands Enzyme Engineering Market Outlook, by End User, 2026-2033
    • 5.5.13. France Enzyme Engineering Market Outlook, by Enzyme Type, 2026-2033
    • 5.5.14. France Enzyme Engineering Market Outlook, by Technology, 2026-2033
    • 5.5.15. France Enzyme Engineering Market Outlook, by Application, 2026-2033
    • 5.5.16. France Enzyme Engineering Market Outlook, by End User, 2026-2033
    • 5.5.17. United Kingdom Enzyme Engineering Market Outlook, by Enzyme Type, 2026-2033
    • 5.5.18. United Kingdom Enzyme Engineering Market Outlook, by Technology, 2026-2033
    • 5.5.19. United Kingdom Enzyme Engineering Market Outlook, by Application, 2026-2033
    • 5.5.20. United Kingdom Enzyme Engineering Market Outlook, by End User, 2026-2033

6. Asia Pacific Enzyme Engineering Market Outlook 2026-2033

  • 6.1. Asia Pacific Enzyme Engineering Market Outlook, by Enzyme Type, Value (US$ Billion), 2026-2033
    • 6.1.1. Hydrolases
    • 6.1.2. Oxidoreductases
    • 6.1.3. Transferases
    • 6.1.4. Lyases
    • 6.1.5. Isomerases
    • 6.1.6. Ligases
  • 6.2. Asia Pacific Enzyme Engineering Market Outlook, by Technology, Value (US$ Billion), 2026-2033
    • 6.2.1. Directed Evolution
    • 6.2.2. Rational Protein Design
    • 6.2.3. Computational and Machine Learning Guided Design
    • 6.2.4. De Novo Enzyme Synthesis
  • 6.3. Asia Pacific Enzyme Engineering Market Outlook, by Application, Value (US$ Billion), 2026-2033
    • 6.3.1. Industrial Biocatalysis
    • 6.3.2. Pharmaceutical and Therapeutic
    • 6.3.3. Food and Beverage Processing
    • 6.3.4. Biofuels and Bioenergy
    • 6.3.5. Diagnostics and Biosensors
  • 6.4. Asia Pacific Enzyme Engineering Market Outlook, by End User, Value (US$ Billion), 2026-2033
    • 6.4.1. Pharmaceutical and Biotechnology Companies
    • 6.4.2. Contract Research and Development Organisations
    • 6.4.3. Food and Beverage Manufacturers
    • 6.4.4. Chemical and Industrial Manufacturers
    • 6.4.5. Academic and Research Institutes
  • 6.5. Asia Pacific Enzyme Engineering Market Outlook, by Country and Subregion, 2026-2033
    • 6.5.1. China Enzyme Engineering Market Outlook, by Enzyme Type, 2026-2033
    • 6.5.2. China Enzyme Engineering Market Outlook, by Technology, 2026-2033
    • 6.5.3. China Enzyme Engineering Market Outlook, by Application, 2026-2033
    • 6.5.4. China Enzyme Engineering Market Outlook, by End User, 2026-2033
    • 6.5.5. India Enzyme Engineering Market Outlook, by Enzyme Type, 2026-2033
    • 6.5.6. India Enzyme Engineering Market Outlook, by Technology, 2026-2033
    • 6.5.7. India Enzyme Engineering Market Outlook, by Application, 2026-2033
    • 6.5.8. India Enzyme Engineering Market Outlook, by End User, 2026-2033
    • 6.5.9. Japan Enzyme Engineering Market Outlook, by Enzyme Type, 2026-2033
    • 6.5.10. Japan Enzyme Engineering Market Outlook, by Technology, 2026-2033
    • 6.5.11. Japan Enzyme Engineering Market Outlook, by Application, 2026-2033
    • 6.5.12. Japan Enzyme Engineering Market Outlook, by End User, 2026-2033
    • 6.5.13. South Korea Enzyme Engineering Market Outlook, by Enzyme Type, 2026-2033
    • 6.5.14. South Korea Enzyme Engineering Market Outlook, by Technology, 2026-2033
    • 6.5.15. South Korea Enzyme Engineering Market Outlook, by Application, 2026-2033
    • 6.5.16. South Korea Enzyme Engineering Market Outlook, by End User, 2026-2033

7. Latin America Enzyme Engineering Market Outlook 2026-2033

  • 7.1. Latin America Enzyme Engineering Market Outlook, by Enzyme Type, Value (US$ Billion), 2026-2033
    • 7.1.1. Hydrolases
    • 7.1.2. Oxidoreductases
    • 7.1.3. Transferases
    • 7.1.4. Lyases
    • 7.1.5. Isomerases
    • 7.1.6. Ligases
  • 7.2. Latin America Enzyme Engineering Market Outlook, by Technology, Value (US$ Billion), 2026-2033
    • 7.2.1. Directed Evolution
    • 7.2.2. Rational Protein Design
    • 7.2.3. Computational and Machine Learning Guided Design
    • 7.2.4. De Novo Enzyme Synthesis
  • 7.3. Latin America Enzyme Engineering Market Outlook, by Application, Value (US$ Billion), 2026-2033
    • 7.3.1. Industrial Biocatalysis
    • 7.3.2. Pharmaceutical and Therapeutic
    • 7.3.3. Food and Beverage Processing
    • 7.3.4. Biofuels and Bioenergy
    • 7.3.5. Diagnostics and Biosensors
  • 7.4. Latin America Enzyme Engineering Market Outlook, by End User, Value (US$ Billion), 2026-2033
    • 7.4.1. Pharmaceutical and Biotechnology Companies
    • 7.4.2. Contract Research and Development Organisations
    • 7.4.3. Food and Beverage Manufacturers
    • 7.4.4. Chemical and Industrial Manufacturers
    • 7.4.5. Academic and Research Institutes
  • 7.5. Latin America Enzyme Engineering Market Outlook, by Country and Subregion, 2026-2033
    • 7.5.1. Brazil Enzyme Engineering Market Outlook, by Enzyme Type, 2026-2033
    • 7.5.2. Brazil Enzyme Engineering Market Outlook, by Technology, 2026-2033
    • 7.5.3. Brazil Enzyme Engineering Market Outlook, by Application, 2026-2033
    • 7.5.4. Brazil Enzyme Engineering Market Outlook, by End User, 2026-2033
    • 7.5.5. Mexico Enzyme Engineering Market Outlook, by Enzyme Type, 2026-2033
    • 7.5.6. Mexico Enzyme Engineering Market Outlook, by Technology, 2026-2033
    • 7.5.7. Mexico Enzyme Engineering Market Outlook, by Application, 2026-2033
    • 7.5.8. Mexico Enzyme Engineering Market Outlook, by End User, 2026-2033
    • 7.5.9. Argentina Enzyme Engineering Market Outlook, by Enzyme Type, 2026-2033
    • 7.5.10. Argentina Enzyme Engineering Market Outlook, by Technology, 2026-2033
    • 7.5.11. Argentina Enzyme Engineering Market Outlook, by Application, 2026-2033
    • 7.5.12. Argentina Enzyme Engineering Market Outlook, by End User, 2026-2033

8. Middle East & Africa Enzyme Engineering Market Outlook 2026-2033

  • 8.1. Middle East & Africa Enzyme Engineering Market Outlook, by Enzyme Type, Value (US$ Billion), 2026-2033
    • 8.1.1. Hydrolases
    • 8.1.2. Oxidoreductases
    • 8.1.3. Transferases
    • 8.1.4. Lyases
    • 8.1.5. Isomerases
    • 8.1.6. Ligases
  • 8.2. Middle East & Africa Enzyme Engineering Market Outlook, by Technology, Value (US$ Billion), 2026-2033
    • 8.2.1. Directed Evolution
    • 8.2.2. Rational Protein Design
    • 8.2.3. Computational and Machine Learning Guided Design
    • 8.2.4. De Novo Enzyme Synthesis
  • 8.3. Middle East & Africa Enzyme Engineering Market Outlook, by Application, Value (US$ Billion), 2026-2033
    • 8.3.1. Industrial Biocatalysis
    • 8.3.2. Pharmaceutical and Therapeutic
    • 8.3.3. Food and Beverage Processing
    • 8.3.4. Biofuels and Bioenergy
    • 8.3.5. Diagnostics and Biosensors
  • 8.4. Middle East & Africa Enzyme Engineering Market Outlook, by End User, Value (US$ Billion), 2026-2033
    • 8.4.1. Pharmaceutical and Biotechnology Companies
    • 8.4.2. Contract Research and Development Organisations
    • 8.4.3. Food and Beverage Manufacturers
    • 8.4.4. Chemical and Industrial Manufacturers
    • 8.4.5. Academic and Research Institutes
  • 8.5. Middle East & Africa Enzyme Engineering Market Outlook, by Country and Subregion, 2026-2033
    • 8.5.1. Saudi Arabia Enzyme Engineering Market Outlook, by Enzyme Type, 2026-2033
    • 8.5.2. Saudi Arabia Enzyme Engineering Market Outlook, by Technology, 2026-2033
    • 8.5.3. Saudi Arabia Enzyme Engineering Market Outlook, by Application, 2026-2033
    • 8.5.4. Saudi Arabia Enzyme Engineering Market Outlook, by End User, 2026-2033
    • 8.5.5. United Arab Emirates Enzyme Engineering Market Outlook, by Enzyme Type, 2026-2033
    • 8.5.6. United Arab Emirates Enzyme Engineering Market Outlook, by Technology, 2026-2033
    • 8.5.7. United Arab Emirates Enzyme Engineering Market Outlook, by Application, 2026-2033
    • 8.5.8. United Arab Emirates Enzyme Engineering Market Outlook, by End User, 2026-2033
    • 8.5.9. South Africa Enzyme Engineering Market Outlook, by Enzyme Type, 2026-2033
    • 8.5.10. South Africa Enzyme Engineering Market Outlook, by Technology, 2026-2033
    • 8.5.11. South Africa Enzyme Engineering Market Outlook, by Application, 2026-2033
    • 8.5.12. South Africa Enzyme Engineering Market Outlook, by End User, 2026-2033
    • 8.5.13. Egypt Enzyme Engineering Market Outlook, by Enzyme Type, 2026-2033
    • 8.5.14. Egypt Enzyme Engineering Market Outlook, by Technology, 2026-2033
    • 8.5.15. Egypt Enzyme Engineering Market Outlook, by Application, 2026-2033
    • 8.5.16. Egypt Enzyme Engineering Market Outlook, by End User, 2026-2033

9. Competitive Landscape

  • 9.1. Competitive Positioning and Strategies
  • 9.2. Company Profiles
    • 9.2.1. Novonesis
    • 9.2.2. BASF SE
    • 9.2.3. International Flavors & Fragrances Inc.
    • 9.2.4. dsm-firmenich AG
    • 9.2.5. Codexis, Inc.
    • 9.2.6. Amano Enzyme Inc.
    • 9.2.7. AB Enzymes GmbH
    • 9.2.8. Dyadic International, Inc.
    • 9.2.9. Advanced Enzyme Technologies Limited
    • 9.2.10. Thermo Fisher Scientific Inc.
    • 9.2.11. Merck KGaA
    • 9.2.12. F. Hoffmann-La Roche Ltd
    • 9.2.13. Kerry Group plc
    • 9.2.14. Ginkgo Bioworks Holdings, Inc.
    • 9.2.15. Arzeda Corp.
    • 9.2.16. Creative Enzymes

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!